aTyr Pharma ATYR Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is aTyr Pharma's stock issuance proceeds?
- aTyr Pharma (ATYR) reported stock issuance proceeds of $0 in Q1 2026.
- How has aTyr Pharma's stock issuance proceeds changed year-over-year?
- aTyr Pharma's stock issuance proceeds decreased by 100.0% year-over-year, from $2K to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.